SCHEMBL1608641

SCHEMBL1608641

CS(=O)(=O)c1ccc(Cn2ccc3ccc(C(=O)NO)cc32)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 14/20 0.70
HDAC6 Q9UBN7 14/20 0.70
HDAC1 Q13547 12/20 0.70
HDAC2 Q92769 9/20 0.70
HDAC3 O15379 8/20 0.70
HDAC10 Q969S8 5/20 0.70
HDAC9 Q9UKV0 3/20 0.70
HDAC11 Q96DB2 3/20 0.70
HDAC4 P56524 2/20 0.70
HDAC7 Q8WUI4 2/20 0.70
HDAC5 Q9UQL6 1/20 0.70
NCOR2 Q9Y618 1/20 0.70
EPHX2 P34913 2/20 0.47
NR1H4 Q96RI1 1/20 0.47
PDE4A P27815 1/20 0.47
PDE4B Q07343 1/20 0.47
PDE4C Q08493 1/20 0.47
PDE4D Q08499 1/20 0.47
RORC P51449 1/20 0.44
PPARG P37231 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1609246 0.88 HDAC8 (0.60) HDAC8HDAC6HDAC1HDAC2HDAC3
SCHEMBL1608684 0.85 HDAC6 (0.76) HDAC8HDAC6HDAC1HDAC2HDAC3
SCHEMBL2115805 0.85 HDAC6 (0.52) HDAC8HDAC6HDAC1HDAC2HDAC3
SCHEMBL17549777 0.84 HDAC6 (0.74) HDAC8HDAC6HDAC1HDAC2HDAC3
SCHEMBL1608483 0.84 HDAC8 (0.74) HDAC8HDAC6HDAC1HDAC2HDAC3
SCHEMBL18085926 0.84 HDAC6 (0.74) HDAC8HDAC6HDAC1HDAC2HDAC3
SCHEMBL1608480 0.83 HDAC6 (0.72) HDAC8HDAC6HDAC1HDAC2HDAC3
SCHEMBL1608706 0.83 HDAC8 (0.72) HDAC8HDAC6HDAC1HDAC2HDAC3
SCHEMBL30014115 0.82 HDAC6 (1.00) HDAC8HDAC6HDAC1HDAC2HDAC3
SCHEMBL1608763 0.82 HDAC6 (1.00) HDAC8HDAC6HDAC1HDAC2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150320758-A1 SELECTIVE INHIBITORS OF HISTONE DEACTYLASE PHARMACYCLICS LLC 2015-11-12 US disclosed
US-8906954-B2 Selective inhibitors of histone deacetylase PHARMACYCLICS, INC. (US) 2014-12-09 US disclosed
US-20140004174-A1 SELECTIVE INHIBITORS OF HISTONE DEACETYLASE PHARMACYCLICS, INC. (US) 2014-01-02 US disclosed
US-8466193-B2 Selective inhibitors of histone deacetylase PHARMACYCLICS, INC. (US) 2013-06-18 US disclosed
US-20110081409-A1 SELECTIVE INHIBITORS OF HISTONE DEACETYLASE PHARMACYCLICS LLC 2011-04-07 US disclosed
EP-2265590-A2 SELECTIVE INHIBITORS OF HISTONE DEACETYLASE PHARMACYCLICS, INC. (US) 2010-12-29 EP disclosed
WO-2009129335-A2 SELECTIVE INHIBITORS OF HISTONE DEACETYLASE PHARMACYCLICS, INC. (US) 2009-10-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110081409-A1 SELECTIVE INHIBITORS OF HISTONE DEACETYLASE HDAC8, HDAC1, HDAC11 HDAC8 1/4885HDAC6 11/4885HDAC1 2/4885
US-20150320758-A1 SELECTIVE INHIBITORS OF HISTONE DEACTYLASE HDAC8, HDAC1, HDAC5 HDAC8 1/4885HDAC6 11/4885HDAC1 2/4885
US-20140004174-A1 SELECTIVE INHIBITORS OF HISTONE DEACETYLASE HDAC8, HDAC1, HDAC11 HDAC8 1/4885HDAC6 11/4885HDAC1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.